Xponance’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $536K | Buy |
12,412
+1,938
| +19% | +$83.7K | ﹤0.01% | 922 |
|
2025
Q1 | $362K | Buy |
10,474
+385
| +4% | +$13.3K | ﹤0.01% | 1032 |
|
2024
Q4 | $277K | Buy |
10,089
+844
| +9% | +$23.2K | ﹤0.01% | 1157 |
|
2024
Q3 | $235K | Buy |
9,245
+374
| +4% | +$9.52K | ﹤0.01% | 1170 |
|
2024
Q2 | $225K | Buy |
8,871
+1,803
| +26% | +$45.7K | ﹤0.01% | 1144 |
|
2024
Q1 | $219K | Buy |
7,068
+106
| +2% | +$3.28K | ﹤0.01% | 1161 |
|
2023
Q4 | $281K | Buy |
+6,962
| New | +$281K | ﹤0.01% | 1073 |
|
2021
Q4 | – | Sell |
-5,053
| Closed | -$237K | – | 1175 |
|
2021
Q3 | $237K | Sell |
5,053
-840
| -14% | -$39.4K | ﹤0.01% | 1091 |
|
2021
Q2 | $359K | Buy |
+5,893
| New | +$359K | 0.01% | 1024 |
|